« Back to Record
Citation APA

Agarwal, N., Hwang, A., Mosher, R., Wasserman, E., Wu, G., Zhang, H., Zieba, R., Elmeliegy, M., Machiels, J. P., Suárez, C., Lewis, N., Higgins, M., Wisinski, K., Awada, A., Maur, M., & Steiner, M. (2016). Phase I study of the prolactin receptor antagonist LFA102 in metastatic breast and castration-resistant prostate cancer. The oncologist, 21(5), 535-536. doi:10.1634/theoncologist.2015-0502


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231565

Agarwal, N., Hwang, A., Mosher, R., Wasserman, E., Wu, G., Zhang, H., Zieba, R., Elmeliegy, M., Machiels, J. P., Suárez, C., Lewis, N., Higgins, M., Wisinski, K., Awada, A., Maur, M., & Steiner, M. (2016). Phase I study of the prolactin receptor antagonist LFA102 in metastatic breast and castration-resistant prostate cancer. The oncologist, 21(5), 535-536. doi:10.1634/theoncologist.2015-0502